ShareValue.ai

ShareValue scores for HIMS: Valuation 40, Quality 21, Growth 49, Health 38.

HIMS
NYSE

Hims Hers Health Inc

$32.71(+0.03%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-10% to 12%
Valuation
40
Overvalued
Price vs Value
Quality
21
Weak
Business Strength
Growth
49
Moderate
Revenue & Earnings
Health
38
Stressed
Financial Stability
Momentum
34
Bearish
Price Trend

Company Details

About

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Score Analysis

AI Investment Thesis

Data as of:Jun 26, 2026
|
Last calculated:Jun 26, 2026